2020 ACOG实践简报:妊娠高血压和先兆子痫

2020-06-12 美国妇产科医师学会 Obstet Gynecol . 2020 Jun;135(6):e237-e260.

2020年6月,美国妇产科医师学会(ACOG)更新了妊娠高血压和先兆子痫指南,妊娠高血压是导致全球孕产妇和围产儿死亡的主要原因,本文主要针对妊娠高血压和先兆子痫的诊断和管理提供指导建议。

中文标题:

2020 ACOG实践简报:妊娠高血压和先兆子痫

英文标题:

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222

发布机构:

美国妇产科医师学会

发布日期:

2020-06-12

简要介绍:

2020年6月,美国妇产科医师学会(ACOG)更新了妊娠高血压和先兆子痫指南,妊娠高血压是导致全球孕产妇和围产儿死亡的主要原因,本文主要针对妊娠高血压和先兆子痫的诊断和管理提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ACOG实践简报:妊娠高血压和先兆子痫.pdf)] GetToolGuiderByIdResponse(projectId=1, id=518d31c00193058c, title=2020 ACOG实践简报:妊娠高血压和先兆子痫, enTitle=Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222, guiderFrom=Obstet Gynecol . 2020 Jun;135(6):e237-e260., authorId=0, author=, summary=2020年6月,美国妇产科医师学会(ACOG)更新了妊娠高血压和先兆子痫指南,妊娠高血压是导致全球孕产妇和围产儿死亡的主要原因,本文主要针对妊娠高血压和先兆子痫的诊断和管理提供指导建议。, cover=https://img.medsci.cn/2020630/1593528724361_2020535.jpg, journalId=0, articlesId=null, associationId=357, associationName=美国妇产科医师学会, associationIntro=美国妇产科医师学会(ACOG),前身为美国妇产科学院,是一个美国妇产科妇科专业医生的专业协会。ACOG拥有超过55000名会员,其中90% 的会员是在美国经执业认证的妇产科医生。Obstetrics & Gynecology是ACOG的官方刊物。通常被称为&ldquo;绿色杂志&rdquo;。 American College of Obstetricians and Gynecologists, copyright=0, guiderPublishedTime=Fri Jun 12 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年6月,美国妇产科医师学会(ACOG)更新了妊娠高血压和先兆子痫指南,妊娠高血压是导致全球孕产妇和围产儿死亡的主要原因,本文主要针对妊娠高血压和先兆子痫的诊断和管理提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=3299, tagName=妊娠高血压)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3299, guiderKeyword=妊娠高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5158, appHits=461, showAppHits=0, pcHits=1417, showPcHits=4697, likes=2, shares=23, comments=24, approvalStatus=1, publishedTime=Tue Jun 30 23:07:42 CST 2020, publishedTimeString=2020-06-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jun 30 22:55:10 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:54:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ACOG实践简报:妊娠高血压和先兆子痫.pdf)])
2020 ACOG实践简报:妊娠高血压和先兆子痫.pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2092935, encodeId=39f02092935a1, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Mon Oct 10 20:43:26 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050125, encodeId=455210501250c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99745436897, createdName=ms5000000092937605, createdTime=Tue Sep 14 01:52:25 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010877, encodeId=fd7e10108e7b9, content=很不错,很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca35582848, createdName=snw715, createdTime=Tue Aug 24 09:12:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010604, encodeId=934910106044b, content=非常值得临床借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04b25093931, createdName=145dc222m30(暂无昵称), createdTime=Mon Aug 23 14:16:32 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976347, encodeId=68c29e63479b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ca5532743, createdName=ms7000000002415593, createdTime=Wed Jun 23 22:16:07 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2022-10-10 ms3000000848423424

    想看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2092935, encodeId=39f02092935a1, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Mon Oct 10 20:43:26 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050125, encodeId=455210501250c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99745436897, createdName=ms5000000092937605, createdTime=Tue Sep 14 01:52:25 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010877, encodeId=fd7e10108e7b9, content=很不错,很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca35582848, createdName=snw715, createdTime=Tue Aug 24 09:12:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010604, encodeId=934910106044b, content=非常值得临床借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04b25093931, createdName=145dc222m30(暂无昵称), createdTime=Mon Aug 23 14:16:32 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976347, encodeId=68c29e63479b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ca5532743, createdName=ms7000000002415593, createdTime=Wed Jun 23 22:16:07 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-09-14 ms5000000092937605

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2092935, encodeId=39f02092935a1, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Mon Oct 10 20:43:26 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050125, encodeId=455210501250c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99745436897, createdName=ms5000000092937605, createdTime=Tue Sep 14 01:52:25 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010877, encodeId=fd7e10108e7b9, content=很不错,很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca35582848, createdName=snw715, createdTime=Tue Aug 24 09:12:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010604, encodeId=934910106044b, content=非常值得临床借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04b25093931, createdName=145dc222m30(暂无昵称), createdTime=Mon Aug 23 14:16:32 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976347, encodeId=68c29e63479b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ca5532743, createdName=ms7000000002415593, createdTime=Wed Jun 23 22:16:07 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-08-24 snw715

    很不错,很有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2092935, encodeId=39f02092935a1, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Mon Oct 10 20:43:26 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050125, encodeId=455210501250c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99745436897, createdName=ms5000000092937605, createdTime=Tue Sep 14 01:52:25 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010877, encodeId=fd7e10108e7b9, content=很不错,很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca35582848, createdName=snw715, createdTime=Tue Aug 24 09:12:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010604, encodeId=934910106044b, content=非常值得临床借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04b25093931, createdName=145dc222m30(暂无昵称), createdTime=Mon Aug 23 14:16:32 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976347, encodeId=68c29e63479b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ca5532743, createdName=ms7000000002415593, createdTime=Wed Jun 23 22:16:07 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-08-23 145dc222m30(暂无昵称)

    非常值得临床借鉴

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2092935, encodeId=39f02092935a1, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Mon Oct 10 20:43:26 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050125, encodeId=455210501250c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99745436897, createdName=ms5000000092937605, createdTime=Tue Sep 14 01:52:25 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010877, encodeId=fd7e10108e7b9, content=很不错,很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca35582848, createdName=snw715, createdTime=Tue Aug 24 09:12:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010604, encodeId=934910106044b, content=非常值得临床借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04b25093931, createdName=145dc222m30(暂无昵称), createdTime=Mon Aug 23 14:16:32 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976347, encodeId=68c29e63479b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ca5532743, createdName=ms7000000002415593, createdTime=Wed Jun 23 22:16:07 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 ms7000000002415593

    实用

    0